Mednax (MD) PT Raised to $37 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- L3Harris CEO steps down amid conduct review, shares drop
Mednax (MD) PT Raised to $37 at BMO Capital
August 10, 2021 9:05 AM EDTBMO Capital analyst Matt Borsch raised the price target on Mednax (NYSE: MD) to $37.00 (from $35.00) while maintaining a Market Perform rating.
The analyst commented, "2Q was very solid with strength fueled by a resurgence of volumes. In fact, current volumes across MD's total... More
